Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Dr. Yasunori Watanabe

London, November 16, 2020 - Elsevier, in partnership with the US-UK Fulbright Commission, announced the winners of the Early Career Researcher (ECR) UK Awards 2020. The ECR Awards champion researchers at an early stage in their career by recognizing their work and awarding each recipient a grant of £1,500. This year’s winners were recognized in a virtual awards ceremony, hosted by science writer and broadcaster Vivienne Parry, OBE and attended by leading experts in higher education from across the UK, the EU and the US.

Elsevier and the US-UK Fulbright Commission remain committed to recognizing and rewarding outstanding young researchers that are making a significant contribution to their field of research, especially during this challenging time, and also recognizing the institutions enabling their work. 

Congratulations to Dr. Yasunori Watanabe, from the Department of Biochemistry,  who was the winner of the Scopus Early Career Researcher Award in Biochemistry, Genetics & Molecular Biology, highlighting his invaluable research in areas including HIV and coronavirus pathobiology.
  
The full story is available on the Department of Biochemistry website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.